Futura Medical plc (FUM) Ordinary GBP0.02
Share news, reports & tips
24 June 2019 09:27
(Sharecast News) - Pharmaceutical company Futura Medical told investors at its annual general meeting on Monday that it had continued to make "good progress" in developing and commercialising its...
19 June 2019 09:58
(Sharecast News) - Pharmaceutical company Futura Medical announced the completion of patient recruitment for the first European phase 3 study of MED2005, 'FM57', on Wednesday, adding that it...
17 June 2019 12:21
(Sharecast News) - Hammerson: Peel Hunt upgrades to add with a target price of 350p.
26 September 2018 16:14
(Sharecast News) - Pharmaceutical group Futura Medical on Wednesday reported an "excellent" first-half as it continued to make progress on the development of two of its main products.
26 April 2018 14:13
(WebFG News) - Advanced transdermal technology-focussed healthcare company Futura Medical updated the market on the planned phase III trials for MED 2002, its topical gel for erectile dysfunction, on Thursday.
25 April 2018 10:38
(WebFG News) - Futura Medical announced on Wednesday that a pharmacokinetic study of MED2002, the company's gel-based erectile dysfunction (ED) treatment, has yielded positive results.
13 March 2018 16:02
(ShareCast News) - Advanced transdermal technology-focussed healthcare company Futura Medical announced positive interim data from its pharmacokinetic study, which formed the initial stage of the Phase III...
29 November 2017 15:03
(ShareCast News) - Transdermal technology-focussed healthcare company Futura Medical announced on Wednesday that recruitment has commenced for its pharmacokinetic (PK) study of MED2002 - its novel gel for...
14 June 2017 14:31
(ShareCast News) - Transdermal technology-focussed healthcare company Futura Medical was set to hold its annual general meeting on Wednesday, with chairman John Clarke telling the gathered investors that the...
6 March 2017 07:51
(ShareCast News) - Futura Medical has commissioned market research that has suggested gel treatment for erectile dysfunction has potential to be sold as an over-the-counter product, with potential peak sales...
Company announcements Announcements
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. This news service is operated by Digital Look Ltd. Republication or redistribution of Digital Look Ltd content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Digital Look Ltd. Please see http://www.DigitalLook.com/newsfeedterms for our terms and conditions.
© Digital Look Ltd 1998-2020. All rights reserved.
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.